Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Natasha Arksey"'
Autor:
Susan M. Hiniker, Quaovi Sodji, Andrew Quon, Paulina M. Gutkin, Natasha Arksey, Edward E. Graves, Frederick T. Chin, Peter G. Maxim, Maximilian Diehn, Billy W. Loo
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Differentiating local recurrence from post-treatment changes on PET scans following stereotactic ablative radiotherapy (SABR) or hyperfractionation for lung tumors is challenging. We performed a prospective pilot study of 3-deoxy-3-[18F]-fluorothymid
Externí odkaz:
https://doaj.org/article/e65d77a62fdd4a1eadd37a60ef8f9062
Autor:
Jean DaSilva, Chad Hunter, Tayebeh Hadizad, Basma Ismail, Mario Tiberi, Maryam Hachem, Rob S. Beanlands, Robert A. deKemp, Natasha Arksey
Publikováno v:
Journal of Nuclear Medicine. 57:1612-1617
Most physiologic effects of the renin angiotensin system (RAS) are mediated via the angiotensin (Ang) type 1 receptor (AT1R). The 18F-FPyKYNE derivative of the clinically used AT1R blocker losartan exhibits high binding selectivity for kidney AT1R an
Autor:
Natasha Arksey, Santoshi Bandla, Steven Roman, Yun Zhu, Yu-Ting Tseng, Fernando Farfan, Fiona Hyland, Brooke McKnight, Chenchen Yang, Charles Scafe, Jigar Patel, Seth Sadis, Xiaoping Duan
Publikováno v:
Cancer Research. 80:1326-1326
Introduction Next-generation sequencing (NGS) is the preferred method to simultaneously characterize multiple relevant genetic variants in cancer samples. In addition to pan-cancer applications, researchers are increasingly interested in cancer type
Autor:
Ana C. Valdivia, Maryam Hachem, Basma Ismail, Natasha Arksey, Robert A. deKemp, Tayebeh Hadizad, Rob S. Beanlands, Jean N. DaSilva
Publikováno v:
Bioorganic & Medicinal Chemistry. 22:3931-3937
The 2-[(18)F]fluoro-3-pent-4-yn-1-yloxypyridine ([(18)F]FPyKYNE) analog of the potent non-peptide angiotensin II type 1 receptor (AT1R) blocker losartan was produced via click chemistry linking [(18)F]FPyKYNE to azide-modified tetrazole-protected los
Autor:
Shawn Scatliffe, Christopher R. McCurdy, Stephanie Chen, Bin Shen, Christopher Lau, Zheng Miao, Ahmad Salehi, Sanjiv S. Gambhir, Kota Kaneshige, Adam J. Shuhendler, Mikael Palner, Lauren Andrews, Frederick T. Chin, Stanley M. Parsons, Michelle L. James, Natasha Arksey
Publikováno v:
EJNMMI research, vol 5, iss 1
EJNMMI Research
EJNMMI Research
Background This study aims to further evaluate the specificity and selectivity of [18F]FTC-146 and obtain additional data to support its clinical translation. Methods The binding of [19F]FTC-146 to vesicular acetylcholine transporter (VAChT) was eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd0279df81ac86a4dd59af3e89ad9560
https://escholarship.org/uc/item/8j9269dt
https://escholarship.org/uc/item/8j9269dt
Autor:
Timothy H. Witney, Michelle L. James, Jianghong Rao, Adam J. Shuhendler, Edwin Chang, Jun Hyung Park, Frederick T. Chin, Christoph Pohling, Bin Shen, Aileen Hoehne, Gayatri Gowrishankar, Deepika Bodapati, Natasha Arksey, Judith Weber, Sanjiv S. Gambhir
Publikováno v:
Witney, T H, James, M L, Shen, B, Chang, E, Pohling, C, Arksey, N, Hoehne, A, Shuhendler, A, Park, J-H, Bodapati, D, Weber, J, Gowrishankar, G, Rao, J, Chin, F T & Gambhir, S S 2015, ' PET imaging of tumor glycolysis downstream of hexokinase through noninvasive measurement of pyruvate kinase M2 ', Science Translational Medicine, vol. 7, no. 310, 310ra169 . https://doi.org/10.1126/scitranslmed.aac6117
Cancer cells reprogram their metabolism to meet increased biosynthetic demands, commensurate with elevated rates of replication. Pyruvate kinase M2 (PKM2) catalyzes the final and rate-limiting step in tumor glycolysis, controlling the balance between
Autor:
Arutselvan, Natarajan, Natasha, Arksey, Andrei, Iagaru, Frederick T, Chin, Sanjiv Sam, Gambhir
Publikováno v:
Molecular imaging. 14
Manufacturing of 64Cu-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-rituximab injection under good manufacturing practices (GMP) was validated for imaging of patients with CD20+ B-cell non-Hodgkin lymphoma. Rituximab was purifi
Autor:
Tony Wyss-Coray, Hongguang Liu, Frederick T. Chin, Lauren Andrews, Zhen Cheng, Zhaoqing Ding, Bin Shen, Deepika Bodapati, Frank M. Longo, Sanjiv S. Gambhir, Nadia P. Belichenko, Michelle L. James, Natasha Arksey, Thuy-Vi V. Nguyen
311 Objectives To analyze the PET/CT imaging characteristics of IgG4 related diseases (IgG4 related diseases, IgG4RD) and investigate the function of 18F-FDG PET/CT in diagnosing of IgG4RD and whole-body evaluation. Methods Whole-body 18F-FDG PET/CT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2bb5c0d99854165fdab6e428462e565
https://europepmc.org/articles/PMC4866832/
https://europepmc.org/articles/PMC4866832/
Autor:
Natasha, Arksey, Tayebeh, Hadizad, Basma, Ismail, Maryam, Hachem, Ana C, Valdivia, Rob S, Beanlands, Robert A, deKemp, Jean N, DaSilva
Publikováno v:
Bioorganicmedicinal chemistry. 22(15)
The 2-[(18)F]fluoro-3-pent-4-yn-1-yloxypyridine ([(18)F]FPyKYNE) analog of the potent non-peptide angiotensin II type 1 receptor (AT1R) blocker losartan was produced via click chemistry linking [(18)F]FPyKYNE to azide-modified tetrazole-protected los